Physician profile
Grace L Schultz
NPI 1598720880
$1,145.89
in general payments reported to CMS, 2019-2025
12 companies · $745 in 2025
The $745 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $64.08 · 2024: $337 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $269.23 | 2024-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $214.77 | 2025 | |
| Novartis Pharmaceuticals Corporation | $142.82 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $134.88 | 2023-2025 | Verquvo, Belsomra |
| Novo Nordisk INC | $125.33 | 2024-2025 | Wegovy |
| Esperion Therapeutics, INC. | $66.99 | 2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $50.08 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.23 | 2024 | Lifevest |
| Azurity Pharmaceuticals, INC. | $37.78 | 2024-2025 | Edarbi |
| Gilead Sciences, INC. | $27.46 | 2023 | |
| Heartflow, INC. | $24.46 | 2025 | |
| Exact Sciences Corporation | $13.86 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.